Physician profile
Mark D Greenberger
NPI 1497860720
$248,881.33
in general payments reported to CMS, 2019-2025
73 companies · $4,218 in 2025
The $4,218 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,236 · 2020: $2,258 · 2021: $3,614 · 2022: $226K · 2023: $4,767 · 2024: $3,629 · 2025: $4,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $229 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,220.90 |
| Travel and Lodging | $229.00 |
| Education | $164.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $221,154.18 | 2022 | |
| Coloplast Corp | $4,713.20 | 2019-2025 | Titan, Porges Coloplast, Speedicath |
| Axonics, INC. | $1,636.60 | 2020-2024 | Axonics, Bulkamid |
| Teleflex LLC | $1,629.56 | 2021-2025 | Urolift, Barrigel |
| Dendreon Pharmaceuticals LLC | $1,595.72 | 2019-2025 | Provenge |
| Medtronic, INC. | $1,575.58 | 2021-2025 | Altaviva, Interstim |
| Medtronic USA, INC. | $1,501.06 | 2019-2020 | |
| Astellas Pharma US INC | $1,489.80 | 2019-2025 | Xtandi, Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $1,433.05 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $1,424.17 | 2019-2025 | Rezum Generator, Axonics, Solyx Sis System |
| Janssen Biotech, INC. | $1,214.07 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Endo Pharmaceuticals INC. | $868.50 | 2019-2024 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $771.52 | 2021-2025 | Jelmyto |
| Neotract INC. | $757.51 | 2019-2020 | |
| Procept Biorobotics Corporation | $742.65 | 2019-2025 | Aquabeam Robotic System, Aquabeam System |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $529.96 | 2019-2025 | |
| Antares Pharma, INC. | $417.97 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Myriad Genetic Laboratories, INC. | $328.46 | 2021-2024 | Prolaris |
| C. R. Bard, INC. & Subsidiaries | $323.98 | 2023-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Merck Sharp & Dohme LLC | $270.28 | 2020-2025 | Lynparza, Keytruda, Welireg |
| Ambu INC. | $257.73 | 2020-2025 | |
| Biotissue Holdings INC. | $253.94 | 2025 | |
| Tolmar, INC. | $253.88 | 2023-2025 | Jatenzo, Eligard |
| Myovant Sciences INC. | $240.41 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $232.86 | 2020-2023 | Lynparza |
| Tolmar Pharmaceuticals, INC. | $190.54 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $181.98 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $150.69 | 2024-2025 | |
| Angiodynamics, INC. | $150.41 | 2024 | Nanoknife |
| Ferring Pharmaceuticals INC. | $148.14 | 2019-2025 | Adstiladrin |
| Endo USA, INC. | $146.84 | 2024-2025 | Xiaflex, Edex, Aveed |
| Rochester Medical Corporation | $146.78 | 2019-2022 | |
| Srs Medical Systems, INC. | $145.64 | 2022 | |
| Blue Earth Diagnostics | $135.86 | 2019-2022 | |
| Abbvie INC. | $128.04 | 2019-2025 | |
| Cook Medical LLC | $126.85 | 2019-2023 | Resonance, Cook |
| Profound Medical Corp. | $107.45 | 2022 | |
| Bard Access Systems, INC. | $105.74 | 2019 | |
| Clarus Therapeutics INC. | $97.08 | 2021 | |
| Karl Storz Endoscopy-America | $93.57 | 2021 | |
| Tempus Ai, INC | $92.44 | 2024-2025 | Xt Cdx |
| Photocure INC | $87.43 | 2021 | |
| Laborie Medical Technologies Corp. | $86.28 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Olympus America INC. | $81.44 | 2024-2025 | Soltive, Itind System |
| Sun Pharmaceutical Industries INC. | $75.13 | 2025 | |
| Accord Healthcare, INC. | $73.65 | 2023-2025 | |
| Amgen INC. | $68.68 | 2022-2023 | Prolia |
| Urovant Sciences INC | $61.07 | 2021-2022 | |
| Travere Therapeutics, INC. | $59.16 | 2019-2020 | |
| Halozyme INC | $46.14 | 2023 | |
| Baxter Healthcare | $37.00 | 2024 | Perclot |
| Foundation Medicine, INC. | $32.46 | 2023 | |
| Allergan, INC. | $31.50 | 2020-2021 | |
| Agiliti Surgical, INC. | $28.45 | 2019 | |
| Integra Lifesciences Corporation | $24.68 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $24.21 | 2023 | Stravix |
| Edap Technomed INC | $24.00 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $23.27 | 2021 | |
| Immunitybio, INC. | $22.65 | 2025 | |
| Novo Nordisk INC | $21.88 | 2024 | Rybelsus |
| Kowa Pharmaceuticals America, INC. | $21.76 | 2023 | Seglentis |
| Cumberland Pharmaceuticals, INC. | $20.88 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $20.27 | 2025 | Exparel, Zilretta, Iovera |
| Therapeuticsmd, INC. | $17.13 | 2019 | |
| Calyxo, INC. | $16.37 | 2025 | Cvac Aspiration System |
| Verity Pharmaceuticals INC. | $15.97 | 2025 | Trelstar |
| Hollister Incorporated | $15.72 | 2022 | |
| Duchesnay USA Incorporated | $15.00 | 2019 | |
| Innovation Technologies INC | $14.77 | 2022 | |
| Axogen | $14.39 | 2019 | |
| Zyla Life Sciences, INC. | $13.06 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.28 | 2020 | |
| Kerecis Limited | $10.96 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$75,182.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Greenberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.